Are Nomograms Useful for Predicting Sentinel Lymph Node Status in Melanoma Patients?

Area of Science:

• Oncology
• Surgical Oncology
• Dermatology

Background:

• Clinical nomograms aim to predict sentinel lymph node (SLN) status in early-stage melanoma.
• The clinical utility of these predictive tools is under ongoing evaluation.
• This study developed and validated a novel nomogram against a benchmark model.

Purpose of the Study:

• To develop and validate a new clinical nomogram for predicting SLN status in early-stage melanoma.
• To compare the accuracy of the developed nomogram with the established Melanoma Institute Australia (MIA) nomogram.
• To assess the current clinical utility of predictive nomograms for SLN status.

Main Methods:

• A logistic regression model was developed using clinicopathological data from the Multicenter Selective Lymphadenectomy Trial-I.
• External validation was performed using the National Cancer Database (NCDB) dataset.
• Performance was evaluated by comparing the area under the curve (AUC) with the MIA nomogram.

Main Results:

• The developed nomogram demonstrated good discrimination for SLN status, with a training set AUC of 0.706.
• On external validation with the NCDB, the model achieved an AUC of 0.715.
• The MIA nomogram achieved a comparable AUC of 0.723 on the same dataset.

Conclusions:

• The newly developed nomogram exhibited performance similar to the established MIA nomogram.
• Despite utilizing different features and datasets, current clinical nomograms lack sufficient accuracy for routine clinical application in melanoma staging.
• Further research is needed to improve the predictive accuracy of nomograms for SLN status.